BioTelemetry, Inc.
(NASDAQ : BEAT)

( )
BEAT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Loading BEAT News...
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-2.90%83.281.0%$474.28m
ABTAbbott Laboratories
-4.34%37.912.7%$402.49m
BSXBoston Scientific Corporation
-2.57%22.381.6%$277.08m
ZBHZimmer Biomet Holdings, Inc.
-3.59%116.583.3%$254.75m
BAXBaxter International Inc.
-4.55%43.8721.8%$221.40m
STJSt. Jude Medical, Inc.
-2.04%76.891.7%$217.54m
TMOThermo Fisher Scientific Inc.
-4.50%145.301.0%$193.60m
ISRGIntuitive Surgical, Inc.
-2.50%644.823.0%$188.93m
SYKStryker Corporation
-1.53%116.571.9%$163.90m
EWEdwards Lifesciences Corporation
-3.09%96.021.7%$148.65m
BDXBecton, Dickinson and Company
-3.21%166.661.5%$138.12m
HOLXHologic, Inc.
-4.24%34.112.9%$120.64m
XRAYDENTSPLY International Inc.
-4.53%61.305.4%$115.41m
BCRC. R. Bard, Inc.
-1.96%226.161.5%$102.90m
LDRHLDR Holding Corporation
0.00%37.038.3%$86.71m

Company Profile

BioTelemetry, Inc. cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. It also develops proprietary integrated patient management platform that incorporates wireless data transmission network. The company operates through operates through the following segments: Healthcare, Technology, and Research. The Healthcare segment focuses on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Technology segment engages in the development, manufacturing, testing, and marketing of medical devices to medical companies, clinics, and hospitals. The Research segment engages in the central core laboratory services that provides cardiac monitoring, scientific consulting, and data management services for drug and medical device trials. BioTelemetry company was founded on April 22, 2013 and is headquartered in Malvern, PA.